BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24266771)

  • 41. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
    Huff SY; Quilliam LA; Cox AD; Der CJ
    Oncogene; 1997 Jan; 14(2):133-43. PubMed ID: 9010215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Untying the Gordian knot of cytokinesis. Role of small G proteins and their regulators.
    Prokopenko SN; Saint R; Bellen HJ
    J Cell Biol; 2000 Mar; 148(5):843-8. PubMed ID: 10704435
    [No Abstract]   [Full Text] [Related]  

  • 43. Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity.
    Maurer T; Garrenton LS; Oh A; Pitts K; Anderson DJ; Skelton NJ; Fauber BP; Pan B; Malek S; Stokoe D; Ludlam MJ; Bowman KK; Wu J; Giannetti AM; Starovasnik MA; Mellman I; Jackson PK; Rudolph J; Wang W; Fang G
    Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5299-304. PubMed ID: 22431598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Redox-sensitive small GTPase H-Ras in murine astrocytes, an
    Zuchegna C; Porcellini A; Messina S
    Redox Rep; 2022 Dec; 27(1):150-157. PubMed ID: 35822835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NMR Technology: The competitive world of RAS biology.
    Luchinat C; Parigi G; Ravera E
    Nat Chem Biol; 2014 Mar; 10(3):173-4. PubMed ID: 24531071
    [No Abstract]   [Full Text] [Related]  

  • 46. RGK proteins: fashioning muscle with “Rad” new brakes.
    Yarotskyy V; Dirksen RT
    Channels (Austin); 2014; 8(4):286-7. PubMed ID: 25478619
    [No Abstract]   [Full Text] [Related]  

  • 47. A Bisphenol by Any Other Name..
    Cox KH
    Endocrinology; 2016 Feb; 157(2):449-51. PubMed ID: 26828808
    [No Abstract]   [Full Text] [Related]  

  • 48. Small molecule binding sites on the Ras:SOS complex can be exploited for inhibition of Ras activation.
    Winter JJ; Anderson M; Blades K; Brassington C; Breeze AL; Chresta C; Embrey K; Fairley G; Faulder P; Finlay MR; Kettle JG; Nowak T; Overman R; Patel SJ; Perkins P; Spadola L; Tart J; Tucker JA; Wrigley G
    J Med Chem; 2015 Mar; 58(5):2265-74. PubMed ID: 25695162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange.
    Burns MC; Sun Q; Daniels RN; Camper D; Kennedy JP; Phan J; Olejniczak ET; Lee T; Waterson AG; Rossanese OW; Fesik SW
    Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3401-6. PubMed ID: 24550516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An orthosteric inhibitor of the RAS-SOS interaction.
    Nickerson S; Joy ST; Arora PS; Bar-Sagi D
    Enzymes; 2013; 34 Pt. B():25-39. PubMed ID: 25034099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling.
    Rahman M; Nguyen TM; Lee GJ; Kim B; Park MK; Lee CH
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K-Ras4b Inhibitors.
    Jeuken S; Shkura O; Röger M; Brickau V; Choidas A; Degenhart C; Gülden D; Klebl B; Koch U; Stoll R; Scherkenbeck J
    ChemMedChem; 2022 Nov; 17(22):e202200392. PubMed ID: 35979853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting the "undruggable" RAS - new strategies - new hope?
    Mörchen B; Shkura O; Stoll R; Helfrich I
    Cancer Drug Resist; 2019; 2(3):813-826. PubMed ID: 35582595
    [No Abstract]   [Full Text] [Related]  

  • 54. Sequence-Selective Covalent CaaX-Box Receptors Prevent Farnesylation of Oncogenic Ras Proteins and Impact MAPK/PI3 K Signaling.
    Franz M; Mörchen B; Degenhart C; Gülden D; Shkura O; Wolters D; Koch U; Klebl B; Stoll R; Helfrich I; Scherkenbeck J
    ChemMedChem; 2021 Aug; 16(16):2504-2514. PubMed ID: 33899342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives.
    Tisi R; Gaponenko V; Vanoni M; Sacco E
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33182807
    [No Abstract]   [Full Text] [Related]  

  • 56. Novel Class of Isoxazole-Based Gelators for the Separation of Bisphenol A from Water and Cleanup of Oil Spills.
    Singh SK; Saha P; Dey S; Nandi S
    ACS Omega; 2020 Apr; 5(15):8613-8618. PubMed ID: 32337424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Environmentally Relevant Concentrations of Bisphenol A Interact with Doxorubicin Transcriptional Effects in Human Cell Lines.
    Ribeiro E; Delgadinho M; Brito M
    Toxics; 2019 Aug; 7(3):. PubMed ID: 31470548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drugging the Small GTPase Pathways in Cancer Treatment: Promises and Challenges.
    Prieto-Dominguez N; Parnell C; Teng Y
    Cells; 2019 Mar; 8(3):. PubMed ID: 30884855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting the Small GTPase Superfamily through Their Regulatory Proteins.
    Gray JL; von Delft F; Brennan PE
    Angew Chem Int Ed Engl; 2020 Apr; 59(16):6342-6366. PubMed ID: 30869179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allosteric Activation of GDP-Bound Ras Isoforms by Bisphenol Derivative Plasticisers.
    Schöpel M; Shkura O; Seidel J; Kock K; Zhong X; Löffek S; Helfrich I; Bachmann HS; Scherkenbeck J; Herrmann C; Stoll R
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.